Stock Analysis

WELL Health Technologies First Quarter 2024 Earnings: Beats Expectations

Simply Wall St

May 09, 2024

WELL Health Technologies (TSE:WELL) First Quarter 2024 Results

Key Financial Results

Revenue: CA$231.6m (up 37% from 1Q 2023).
Net income: CA$15.1m (up from CA$14.4m loss in 1Q 2023).
Profit margin: 6.5% (up from net loss in 1Q 2023).
EPS: CA$0.062 (up from CA$0.062 loss in 1Q 2023).

earnings-and-revenue-growth — TSX:WELL Earnings and Revenue Growth May 9th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

WELL Health Technologies Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates.

Looking ahead, revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Healthcare industry in Canada.

Performance of the Canadian Healthcare industry.

The company's shares are up 10% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for WELL Health Technologies that you need to take into consideration.

Valuation is complex, but we're helping make it simple.

Find out whether WELL Health Technologies is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.